Troy Wilson
About Troy Wilson
Troy Wilson is a distinguished leader in the biotechnology sector, currently serving as the President and CEO of multiple biotech firms and holding significant academic credentials in bioorganic chemistry and biophysics.
Troy Wilson Title and Current Positions
Troy Wilson serves as the President and Chief Executive Officer. He holds multiple board positions, including Chairman and member of the Board of Directors at Avidity Biosciences, Inc., and Executive Chairman and member of the Board of Directors at Wellspring Biosciences. Additionally, he is a member of the Board of Managers at Araxes Pharma LLC and has been on the Board of Directors of Puma Biotechnology, Inc. since October 2013.
Troy Wilson Education and Expertise
Troy Wilson holds a Ph.D. in bioorganic chemistry and a J.D. from New York University. Prior to these accomplishments, he earned a B.A. in biophysics and a Ph.D. in bioorganic chemistry from the University of California, Berkeley. This educational foundation has equipped him with a deep understanding of both scientific and legal domains.
Troy Wilson Professional Background
Troy Wilson has an extensive background in leading biotechnology companies. He was President and CEO of Wellspring Biosciences, Inc. and its parent company Araxes Pharma LLC from July 2012 to March 2019. He also served as President and CEO of Avidity Biosciences, Inc. from November 2012 to February 2019. Additionally, he led Intellikine, Inc. as President and CEO from April 2007 to January 2012. His leadership roles have spanned various innovative biotech firms, highlighting his substantial experience in the industry.
Troy Wilson Board Memberships
Troy Wilson is an active member of several boards in the biotechnology sector. He has served on the Board of Directors of Puma Biotechnology, Inc. since October 2013. At Avidity Biosciences, Inc., he has been a member of the Board of Directors since November 2012, later becoming the Chairman in February 2019. Similarly, he has been part of the Board of Directors of Wellspring Biosciences since July 2012 and took on the role of Executive Chairman in February 2019. He is also a member of the Board of Managers of Araxes Pharma LLC.